James S. McElvain

Prior to joining Brickell, Dr. McElvain has consulted for multiple pharmaceutical companies in CMC Head and leadership roles including CMC Operations, Process Development, Formulation Development, Analytical Development, Manufacturing, Supply Chain, and Quality organizations. Before becoming a pharmaceutical CMC consultant, Dr. McElvain was Vice President and Head of the Quality and Analytical Departments at Kythera Biopharmaceuticals (acquired by Allergan in 2015) in Westlake Village, CA, and contributed to the successful CMC development and commercialization of Kybella®/Belkyra™. Prior to joining Kythera, Dr. McElvain held various small molecule analytical and bioanalytical leadership positions at Amgen in Thousand Oaks, CA, and Hoechst Marion Roussel in Kansas City, MO.